Gentaur Nivolumab – Anti-PD-1 Antibody
A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.
Garantie satisfait ou remboursé de 30 jours
Livraison : 2-3 jours ouvrables